glp-1 heart muscle Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists The Cardiovascular Physiology of Glucagon-like

Choosing between semaglutide and tirzepatide with Hashimoto's Both semaglutide and tirzepatide are options for Hashimoto's patients, but they work differently and have distinct considerations worth understanding

Back Edwards, K, Li, X, Linvay, I (1 April 2023) 'Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study', The Journal of Clinical Endocrinology & Metabolism , 108/ 4, 92030

Jody Dushay, M.D., is an assistant professor of medicine at Harvard Medical School and an attending endocrinologist at Beth Israel Deaconess Medical Center

Significant weight loss

Real needle-free options exist: the Wegovy oral tablet (FDA-approved December 2025) and experimental microneedle patches in early clinical trials

[DOI] [PMC free article] [PubMed] [Google Scholar] 22.Subar A.F., Kirkpatrick S.I., Mittl B., et al